Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18215434rdf:typepubmed:Citationlld:pubmed
pubmed-article:18215434lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0599880lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0449468lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0600521lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C1512814lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:18215434lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:18215434pubmed:issue1lld:pubmed
pubmed-article:18215434pubmed:dateCreated2008-7-8lld:pubmed
pubmed-article:18215434pubmed:abstractTextTo compare the dose coverage of planning and clinical target volume (PTV, CTV), and organs-at-risk (OAR) between intensity-modulated (3D-IMRT) and conventional conformal radiotherapy (3D-CRT) before and after internal organ variation in prostate cancer.lld:pubmed
pubmed-article:18215434pubmed:languageenglld:pubmed
pubmed-article:18215434pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18215434pubmed:citationSubsetIMlld:pubmed
pubmed-article:18215434pubmed:statusMEDLINElld:pubmed
pubmed-article:18215434pubmed:monthJullld:pubmed
pubmed-article:18215434pubmed:issn0167-8140lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:CoatJ PJPlld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:DuboisJean-Be...lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:GourgouSophie...lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:FenogliettoPa...lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:AilleresNorbe...lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:IdriKatiaKlld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:AllawAliAlld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:MoscardoCarme...lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:HayMeng...lld:pubmed
pubmed-article:18215434pubmed:authorpubmed-author:LaliberteBeno...lld:pubmed
pubmed-article:18215434pubmed:issnTypePrintlld:pubmed
pubmed-article:18215434pubmed:volume88lld:pubmed
pubmed-article:18215434pubmed:ownerNLMlld:pubmed
pubmed-article:18215434pubmed:authorsCompleteYlld:pubmed
pubmed-article:18215434pubmed:pagination77-87lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:meshHeadingpubmed-meshheading:18215434...lld:pubmed
pubmed-article:18215434pubmed:year2008lld:pubmed
pubmed-article:18215434pubmed:articleTitlePersistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.lld:pubmed
pubmed-article:18215434pubmed:affiliationDépartement d'Oncologie Radiothérapie, CRLC Val d'Aurelle-Paul Lamarque, Montpellier, France. pfenoglietto@valdorel.fnclcc.frlld:pubmed
pubmed-article:18215434pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18215434pubmed:publicationTypeComparative Studylld:pubmed